RenovaCare, Inc. (RCAR)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
May 27, 2025, 4:00 PM EDT
RenovaCare Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
87.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| Silence Therapeutics | 27.70M |
| American Oncology Network | 1.76B |
RenovaCare News
- 3 months ago - RenovaCare Inc. Provides Notice of Proposed Derivative Settlement to All Record Holders and Beneficial Owners of RenovaCare, Inc. - Business Wire
- 4 months ago - Hagens Berman Sobol Shapiro LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of RenovaCare Securities - RCAR - GlobeNewsWire
- 3 years ago - RenovaCare Announces Termination of StemCell Systems R&D Agreement - GlobeNewsWire
- 3 years ago - SHAREHOLDER ALERT: Rigrodsky Law, P.A. is Investigating RenovaCare, Inc. - Newsfile Corp
- 3 years ago - RenovaCare Announces Management Changes - GlobeNewsWire
- 3 years ago - RenovaCare Provides Clinical and Corporate Update - GlobeNewsWire
- 3 years ago - RM LAW Announces Investigation of RenovaCare, Inc. - PRNewsWire
- 3 years ago - SHAREHOLDER ALERT: Robbins LLP Investigates RenovaCare, Inc. (RCAR) on Behalf of Investors - Business Wire